Emergence of BRCA Reversion Mutations in Prostate Cancer Prior to PARP Inhibitor Exposure: Clinical and Therapeutic Implications. [PDF]
Lin DI +11 more
europepmc +1 more source
Clinical characteristics of endometrial cancers with microsatellite instability-high and <i>BRCA1/2</i> mutations. [PDF]
Shan Y +6 more
europepmc +1 more source
Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield. [PDF]
Bonamici L +14 more
europepmc +1 more source
Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance. [PDF]
McGehee CD +19 more
europepmc +1 more source
A predictive model based on BRCA1/2, POLE, TP53, and MSH6 mutations for immunotherapy response in advanced endometrial cancer. [PDF]
Jia Y +5 more
europepmc +1 more source
Prevalence and Clinical Associations of Germline DDR Variants in Prostate Cancer: Real-World Evidence from a 122-Patient Turkish Cohort. [PDF]
Akay S +4 more
europepmc +1 more source
Germline variant spectrum of hereditary cancer susceptibility genes in a Chinese cohort. [PDF]
Xiong C +10 more
europepmc +1 more source
Screening of the founder pathogenic variants BRCA1 and BRCA2 in Russian metropolitan women. [PDF]
Bodunova N +9 more
europepmc +1 more source

